The median plasma VEGF 165 level of the NSCLC patients was 707.0 pg/ml, ranging between 452 and 2,058 pg/ml (mean ± SD, 773.1±288.6 pg/ml). Here, VEGFA is linked to non-small cell lung carcinoma.